Friess Associates’s QuidelOrtho QDEL Stock Holding History

Friess Associates’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-68,612	Closed	-$5.15M	–	134
2019 Q4	$5.15M	Buy	+68,612	New	+$4.43M	0.36%	77

Other funds holding QDEL

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Friess Associates's QDEL Position: Q1 2020 in Review

Friess Associates sold out of QuidelOrtho (QDEL) in Q1 2020, closing a stake of 68,612 shares — an estimated $5.15M sold.

Friess Associates first reported a position in QDEL in Q4 2019 and held it in 1 quarter. The position peaked at $5.15M in Q4 2019. 226 funds tracked by Wall St. Rank hold QDEL as of Q1 2020.

Friess Associates reported no remaining QuidelOrtho position as of Q1 2020 after selling out during the quarter.
Friess Associates sold 68,612 QuidelOrtho shares in Q1 2020, an estimated $5.15M.
Friess Associates first reported a position in QuidelOrtho in Q4 2019 and held it in 1 quarter.
Friess Associates's QuidelOrtho position peaked at $5.15M in Q4 2019.
226 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2020.

Based on Friess Associates's 13F filing for Q1 2020, filed 15 May 2020.